Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA

This study has been completed.
Sponsor:
Collaborator:
Siriraj Hospital
Information provided by:
Mahidol University
ClinicalTrials.gov Identifier:
NCT00795223
First received: November 20, 2008
Last updated: September 28, 2009
Last verified: September 2009
  Purpose

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block


Condition Intervention Phase
Post Operative Pain
Total Knee Replacement
Drug: morphine and bupivacaine
Drug: spinal morphine and marcaine
Drug: morphine and bupivacaine
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparative Effect of 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for Femoral Nerve Block After Total Knee Replacement

Resource links provided by NLM:


Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • Global assessment in post operative pain control [ Time Frame: Begining of first enrollment in december 2008 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Global assessment of post operative pain in 48 HOURS AND SIDE EFFECTS [ Time Frame: first enrollment in December 2008 ] [ Designated as safety issue: No ]

Enrollment: 160
Study Start Date: October 2008
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Injection of 0.3 mg morphine with spinal block and perform femoral nerve block with 0.5% bupivacaine
Drug: morphine and bupivacaine
0.3 mg morphine for spinal together with 0.5% bupivacaine for femoral nerve block
Other Name: marcaine
Active Comparator: 2
Injection of 0.3 mg morphine with spinal block and perform femoral nerve block with 0.25% bupivacaine
Drug: spinal morphine and marcaine
0.3 mg spinal morphine together with 0.25% bupivacaine for femoral nerve block
Other Name: marcaine
Active Comparator: 3
Injection of 0.2 mg morphine with spinal block and perform femoral nerve block with 0.5% bupivacaine
Drug: morphine and bupivacaine
0.2 mg morphine for spinal 0.5% bupivacaine for femoral nerve block
Other Name: marcaine
Active Comparator: 4
Injection of 0.2 mg morphine with spinal block and perform femoral nerve block with 0.25% bupivacaine
Drug: morphine and bupivacaine
0.2 mg morphine for spinal together with 0.25% bupivacaine for femoral nerve block
Other Name: marcaine

  Eligibility

Ages Eligible for Study:   45 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Single elective total knee replacement in ASA 1-3 without significant cardiovascular limitation

Exclusion Criteria:

  • patient at risk in usage COX-2 for post operative pain control
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00795223

Locations
Thailand
Siriraj Hospital
Bangkok, Bangkoknoi, Thailand, 10700
Sponsors and Collaborators
Mahidol University
Siriraj Hospital
Investigators
Principal Investigator: Thitima Chinachoti, MD Siriraj Hospital
  More Information

No publications provided

Responsible Party: Thitima Chinachoti, Siriraj Hospital
ClinicalTrials.gov Identifier: NCT00795223     History of Changes
Other Study ID Numbers: 461/2551(EC1), Grant by the siriraj Hospital
Study First Received: November 20, 2008
Last Updated: September 28, 2009
Health Authority: Thailand: Ethical Committee

Additional relevant MeSH terms:
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Signs and Symptoms
Bupivacaine
Morphine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses
Analgesics, Opioid
Analgesics
Narcotics

ClinicalTrials.gov processed this record on July 20, 2014